Tag: Diabetes: Type I

Poor blood sugar control in adolescence increases likelihood for developing neuropathy in adulthood

Author says findings support previous clinical trial data showing efficacy of baricitinib in preserving beta cell function in T1D

ATG 2.5 and 0.5 mg/kg reduces loss of β-cell function in young people with recent-onset type 1 diabetes

Lower mean HbA1c levels seen for centers with full reimbursement for CGM, CSII, glucometers, and insulin

Sharp decline seen in work-related income, with relative decrease of 6.6 and 1.6 percent for mothers and fathers, respectively, in year after diagnosis

Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured

Participants did not have islet autoantibodies and had significantly lower median type 1 diabetes genetic risk score

Risk for MACE lower in adult-onset T1D versus T2D, but mortality higher from diabetic coma or ketoacidosis

GLP-1 receptor agonist prescriptions increased significantly during study period across all categories of BMI, in dose-response manner

Low-glucose alerts improve time below range for drivers with T1D and reduce incidence of low glucose for all insulin-treated drivers